Literature DB >> 28636438

Oxidative stress mediated by nitrogen at elevated pressure inhibits non-small cell lung cancer growth.

Stephen R Thom1, Mark Ma1, Veena M Bhopale1, Cindy Zhou1, Li Mao1.   

Abstract

Purpose/Aim: High pressures of gases such as nitrogen enhance production of singlet oxygen. Therefore, we hypothesized that growth of non-small cell lung cancer (NSCLC) A549 cells and a human-derived NSCLC explant could be inhibited by an oxidative stress mechanism using high-pressure nitrogen.
MATERIALS AND METHODS: Growth of human NSCLC explants and A549 cells in Matrigel were assessed after implantation into nude mice who were exposed to elevated pressures.
RESULTS: Subcutaneous implant growth of NSCLC in nude mice was inhibited by a daily 78-minute protocol using nitrogen/oxygen breathing mixture such that at the maximum pressure of 2.78 atmospheres over ambient, mice breathed oxygen at normal atmospheric pressure. In vivo growth inhibition of A549 cells by high-pressure nitrogen could be abrogated in subcutaneous Matrigel implants when supplemented with 10-mM N-acetylcysteine as an antioxidant. Ex vivo A549 cell exposures exhibited elevated singlet oxygen production, and reactive oxygen species were produced for up to 4 hours after short-term high-pressure nitrogen exposure.
CONCLUSIONS: This pilot study demonstrates that elevated normoxic nitrogen pressure can exacerbate oxidative stress in NSCLC to inhibit growth.

Entities:  

Keywords:  A549; NADPH oxidase; human hetero-transplant; singlet oxygen

Mesh:

Substances:

Year:  2017        PMID: 28636438     DOI: 10.1080/01902148.2017.1331478

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  1 in total

1.  Association Between Heart Rate Variability and Decompression-Induced Physiological Stress.

Authors:  Sergio Rhein Schirato; Ingrid El-Dash; Vivian El-Dash; Bruna Bizzarro; Alessandro Marroni; Massimo Pieri; Danilo Cialoni; José Guilherme Chaui-Berlinck
Journal:  Front Physiol       Date:  2020-07-03       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.